{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:36:50Z","timestamp":1792265810415,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008459","name":"University of Calgary","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejphar.2024.176416","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T21:44:19Z","timestamp":1707515059000},"page":"176416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Effect of ABT-639 on Cav3.2 channel activity and its analgesic actions in mouse models of inflammatory and neuropathic pain"],"prefix":"10.1016","volume":"967","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0620-2984","authenticated-orcid":false,"given":"Flavia Tasmin Techera","family":"Antunes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0563-8956","authenticated-orcid":false,"given":"Sun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald W.","family":"Zamponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.176416_bib1","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1021\/acschemneuro.3c00083","article-title":"Icariside II, a prenyl-flavonol, alleviates inflammatory and neuropathic pain by inhibiting T-type calcium channels and USP5-cav3.2 interactions","volume":"14","author":"Ali","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176416_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119223","article-title":"Current drug development overview: targeting voltage-gated calcium channels for the treatment of pain","volume":"24","author":"Antunes","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176416_bib3","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/17512433.2022.2114898","article-title":"Opioid epidemic: lessons learned and updated recommendations for misuse involving prescription versus non-prescription opioids","volume":"15","author":"Bedene","year":"2022","journal-title":"Expet Rev. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176416_bib4","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00424-014-1566-3","article-title":"1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain","volume":"467","author":"Bladen","year":"2015","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.ejphar.2024.176416_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.emboj.7600515","article-title":"Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception","volume":"24","author":"Bourinet","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2024.176416_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/bja\/aev198","article-title":"Chronic intrathecal infusion of mibefradil, ethosuximide and nickel attenuates nerve ligation-induced pain in rats","volume":"115","author":"Chen","year":"2015","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejphar.2024.176416_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FBP.0b013e3280141375","article-title":"Effects of intrathecal injection of T-type calcium channel blockers in the rat formalin test","volume":"18","author":"Cheng","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176416_bib8","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","article-title":"Chronic pain: an update on burden, best practices, and new advances","volume":"397","author":"Cohen","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2024.176416_bib9","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4161\/chan.25867","article-title":"Modeling interactions between voltage-gated Ca (2+) channels and KCa1.1 channels","volume":"7","author":"Engbers","year":"2013","journal-title":"Channels"},{"key":"10.1016\/j.ejphar.2024.176416_bib10","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/19336950.2017.1326233","article-title":"Down-regulation of T-type Cav3.2 channels by hyperpolarization-activated cyclic nucleotide-gated channel 1 (HCN1): evidence of a signaling complex","volume":"11","author":"Fan","year":"2017","journal-title":"Channels"},{"key":"10.1016\/j.ejphar.2024.176416_bib11","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0028-3908(01)00142-3","article-title":"Evidence for the participation of kinins in Freund's adjuvant-induced inflammatory and nociceptive responses in kinin B1 and B2 receptor knockout mice","volume":"41","author":"Ferreira","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2024.176416_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13041-023-01036-8","article-title":"Analgesia by intrathecal delta-9-tetrahydrocannabinol is dependent on Cav3.2 calcium channels","volume":"16","author":"Gadotti","year":"2023","journal-title":"Mol. Brain"},{"key":"10.1016\/j.ejphar.2024.176416_bib13","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1097\/j.pain.0000000000002651","article-title":"Ca V 3.2 calcium channels contribute to trigeminal neuralgia","volume":"163","author":"Gambeta","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2024.176416_bib14","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.neuron.2014.07.036","article-title":"The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity","volume":"83","author":"Garc\u00eda-Caballero","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2024.176416_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202313461","article-title":"Analgesic buxus alkaloids with enhanced selectivity for the low-voltage-gated calcium channelchannel Ca","volume":"63","author":"Gong","year":"2024","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejphar.2024.176416_bib16","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1111\/bph.15498","article-title":"The T-type calcium channel antagonist, Z944, reduces spinal excitability and pain hypersensitivity","volume":"178","author":"Harding","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176416_bib17","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/bph.16035","article-title":"Differential regulation of Cav3.2 and Cav 2.2 calcium channels by CB1 receptors and cannabidiol","volume":"180","author":"Harding","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176416_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13041-022-00923-w","article-title":"Central and peripheral contributions of T-type calcium channels in pain","volume":"15","author":"Harding","year":"2022","journal-title":"Mol. Brain"},{"key":"10.1016\/j.ejphar.2024.176416_bib19","doi-asserted-by":"crossref","first-page":"e774","DOI":"10.1097\/j.pain.0000000000002465","article-title":"Voltage-gated calcium currents in human dorsal root ganglion neurons","volume":"163","author":"Hartung","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2024.176416_bib20","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuroscience.2006.07.010","article-title":"Temperature dependence of T-type calcium channel gating","volume":"142","author":"Iftinca","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2024.176416_bib21","doi-asserted-by":"crossref","first-page":"9374","DOI":"10.1523\/JNEUROSCI.0068-12.2012","article-title":"Presynaptic Cav3.2 channels regulate excitatory neurotransmission in nociceptive dorsal horn neurons","volume":"32","author":"Jacus","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176416_bib22","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.bcp.2014.03.015","article-title":"A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats","volume":"89","author":"Jarvis","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176416_bib23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/j.pain.0000000000000362","article-title":"T-type calcium channel blocker Z944 restores cortical synchrony and thalamocortical connectivity in a rat model of neuropathic pain","volume":"157","author":"LeBlanc","year":"2016","journal-title":"Pain"},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2024.176416_bib24","first-page":"S11","article-title":"Z944: a first in class T-type calcium channel modulator for the treatment of pain","volume":"19","author":"Lee","year":"2014","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.ejphar.2024.176416_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00424-015-1733-1","article-title":"Effect of the T-type channel blocker KYS-05090S in mouse models of acute and neuropathic pain","volume":"468","author":"M'Dahoma","year":"2016","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.ejphar.2024.176416_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0304-3959(98)00045-1","article-title":"Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates","volume":"76","author":"Malmberg","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2024.176416_bib27","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1074\/jbc.M008215200","article-title":"Molecular and functional characterization of a family of rat brain T-type calcium channels","volume":"276","author":"McRory","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2024.176416_bib28","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/j.1532-2149.2011.00107.x","article-title":"The association between pain intensity and the prescription of analgesics and non-steroidal anti-inflammatory drugs","volume":"16","author":"Muller","year":"2012","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejphar.2024.176416_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3344\/kjp.2010.23.2.99","article-title":"Pharmacologic management of chronic pain","volume":"23","author":"Park","year":"2010","journal-title":"Korean J Pain"},{"key":"10.1016\/j.ejphar.2024.176416_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/204946370900300102","article-title":"The cost and burden of chronic pain","volume":"3","author":"Phillips","year":"2009","journal-title":"Rev Pain"},{"key":"10.1016\/j.ejphar.2024.176416_bib31","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/bph.14608","article-title":"Inhibition of Ca(v) 3.2 calcium channels: a new target for colonic hypersensitivity associated with low-grade inflammation","volume":"176","author":"Picard","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176416_bib32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/bph.15956","article-title":"Role of T CD4 + cells, macrophages, C-low threshold mechanoreceptors and spinal Ca v 3.2 channels in inflammation and related pain-like symptoms in murine inflammatory models","volume":"180","author":"Picard","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176416_bib33","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1097\/j.pain.0000000000000249","article-title":"Effects of a T-type calcium channel blocker, ABT-639, on spontaneous activity in C-nociceptors in patients with painful diabetic neuropathy: a randomized controlled trial","volume":"156","author":"Serra","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2024.176416_bib34","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1111\/bph.13906","article-title":"Recent advances in the development of T-type calcium channel blockers for pain intervention","volume":"175","author":"Snutch","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176416_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/j.pain.0000000000001384","article-title":"Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the international classification of diseases (ICD-11)","volume":"160","author":"Treede","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2024.176416_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003120","article-title":"T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures","volume":"4","author":"Tringham","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejphar.2024.176416_bib37","first-page":"551","article-title":"A randomized, double-blind, placebo-controlled, crossover study of the T-type calcium channel blocker ABT-639 in an intradermal capsaicin experimental pain model in healthy adults","volume":"17","author":"Wallace","year":"2016","journal-title":"Pain Med."},{"key":"10.1016\/j.ejphar.2024.176416_bib38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.biocel.2019.01.008","article-title":"T-type calcium channels: from molecule to therapeutic opportunities","volume":"108","author":"Weiss","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejphar.2024.176416_bib39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000276981","article-title":"The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia","volume":"85","author":"Wen","year":"2010","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejphar.2024.176416_bib40","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuron.2023.01.007","article-title":"A cellular taxonomy of the adult human spinal cord","volume":"111","author":"Yadav","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2024.176416_bib41","doi-asserted-by":"crossref","first-page":"ra94","DOI":"10.1126\/scisignal.2005283","article-title":"Peripheral pain is enhanced by insulin-like growth factor 1 through a G protein-mediated stimulation of T-type calcium channels","volume":"7","author":"Zhang","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ejphar.2024.176416_bib42","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1097\/j.pain.0000000000000263","article-title":"A randomized double-blind, placebo-, and active-controlled study of T-type calcium channel blocker ABT-639 in patients with diabetic peripheral neuropathic pain","volume":"156","author":"Ziegler","year":"2015","journal-title":"Pain"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924001043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924001043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:31:15Z","timestamp":1757979075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924001043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":42,"alternative-id":["S0014299924001043"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176416","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of ABT-639 on Cav3.2 channel activity and its analgesic actions in mouse models of inflammatory and neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"176416"}}